PL9: 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE
PL9 is a Ligand Of Interest in 4RVY designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4RVY_PL9_d_408 | 4% | 44% | 0.401 | 0.774 | 0.8 | 1.33 | 1 | 9 | 0 | 0 | 100% | 1 |
4RVY_PL9_D_408 | 1% | 44% | 0.511 | 0.697 | 0.8 | 1.33 | 1 | 9 | 0 | 0 | 100% | 1 |
4RVY_PL9_a_613 | 0% | 41% | 1.476 | 0.261 | 0.71 | 1.57 | 2 | 13 | 0 | 0 | 100% | 1 |
4RVY_PL9_A_613 | 0% | 41% | 1.953 | 0.336 | 0.71 | 1.56 | 2 | 13 | 0 | 0 | 100% | 1 |
5V2C_PL9_d_407 | 96% | 34% | 0.069 | 0.978 | 1.27 | 1.32 | 8 | 10 | 0 | 0 | 100% | 1 |
5B66_PL9_D_412 | 93% | 35% | 0.077 | 0.97 | 1.06 | 1.51 | 3 | 12 | 0 | 0 | 100% | 1 |
5ZZN_PL9_D_407 | 92% | 34% | 0.081 | 0.973 | 1.11 | 1.47 | 6 | 7 | 0 | 0 | 100% | 1 |
8F4C_PL9_D_407 | 90% | 33% | 0.083 | 0.964 | 0.91 | 1.71 | 3 | 14 | 0 | 0 | 100% | 1 |
7YQ7_PL9_d_408 | 89% | 42% | 0.083 | 0.961 | 0.77 | 1.47 | 2 | 13 | 0 | 0 | 100% | 1 |
8F4J_PL9_D_406 | 89% | 32% | 0.083 | 0.961 | 0.92 | 1.75 | 2 | 12 | 0 | 0 | 100% | 1 |